A Medical Breakthrough for Postpartum Depression Within a Deeply Flawed System
(MedPage Today) — The FDA approval of the postpartum depression (PPD) pill zuranolone (Zurzuvae), based on two successful phase III trials, represents a scientific triumph. This neuroactive steroid-based treatment joins a related treatment, IV…
Powered by WPeMatico
